MedPath

PERGILAS CASPOFUNGIN 50 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION

Registration Number: MAL21046012ACRZ

Approved
Approval ID

dec8d5be43462c4f

Registration Number

MAL21046012ACRZ

Registration Date

Jul 7, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 7, 2025

PACKAGING INFORMATION (1)

10 ml VialsAvailable
Package Size: 10 ml Vials
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

CASPOFUNGIN ACETATEActive
Monograph: 卡泊芬净

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PERGILAS CASPOFUNGIN 50 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform